Estimated deaths per 100.000 prevented or added in 2040.

<p>Estimated deaths by risk factor change, under three risk factor scenarios.</p

Data sources.

<p>CHD mortality in 2010 was not available.</p

Data on sample characteristics and risk factor values from the Reykjavik study (1981) and REFINE Reykjavik study (2006 and 2010).

<p>Data on sample characteristics and risk factor values from the Reykjavik study (1981) and REFINE Reykjavik study (2006 and 2010).</p

Population numbers and CHD deaths in Iceland in 2010, and expected population numbers and CHD deaths in 2040 if 2010 rates persist.

<p>Population numbers and CHD deaths in Iceland in 2010, and expected population numbers and CHD deaths in 2040 if 2010 rates persist.</p

Future CHD mortality rate among 25–74 year old Icelanders in three different risk factor scenarios.

<p>Future CHD mortality rate among 25–74 year old Icelanders in three different risk factor scenarios.</p

CHD deaths per 100,000 prevented or added as a result of risk factor changes, under three cardiovascular risk factor scenarios.

<p>May not sum to total due to rounding.</p

Overview of three future risk factor scenarios.

<p>Overview of three future risk factor scenarios.</p

Future CHD mortality rate among 25–74 year old Icelanders.

<p>Future CHD mortality in two different risk factor scenarios and a proposal to obtainable goals.</p

Glucose metabolic derangements and carotid plaque burden.

<p>Glucose metabolic derangements and carotid plaque burden.</p

Pertinent characteristics of patients divided according to their glucose metabolism.

<p>Pertinent characteristics of patients divided according to their glucose metabolism.</p